who should not take glp 1 receptor agonists GLP-1 Medications: Everything You Need to Know Trends in the Development of
Description
Eur Neuropsychopharmacol
Bliddal M, Nohmie G, Damkier P, Pottegard A
A., Engedal K., Whist J
doi: 10.1007/s40256-024-00707-8 36 American Diabetes Association Professional Practice Committee
However, the use of this medication requires a prolonged initial treatment period of dose-escalation to attenuate the adverse gastrointestinal effects (nausea, vomiting, diarrhea) typically associated with GLP-1R agonists, which still occurred frequently but rarely resulted in discontinuation of treatment
coli , induced by liraglutide administration
